Gentian Diagnostics ASA (OSL:GENT)
Norway flag Norway · Delayed Price · Currency is NOK
54.80
-0.20 (-0.36%)
At close: Dec 5, 2025

Gentian Diagnostics ASA Revenue

Gentian Diagnostics ASA had revenue of 41.84M NOK in the quarter ending September 30, 2025, with 27.94% growth. This brings the company's revenue in the last twelve months to 172.52M, up 17.42% year-over-year. In the year 2024, Gentian Diagnostics ASA had annual revenue of 152.07M with 12.52% growth.

Revenue (ttm)
172.52M
Revenue Growth
+17.42%
P/S Ratio
4.90
Revenue / Employee
2.74M
Employees
63
Market Cap
845.14M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024152.07M16.92M12.52%
Dec 31, 2023135.15M23.23M20.76%
Dec 31, 2022111.92M11.91M11.91%
Dec 31, 2021100.01M21.13M26.78%
Dec 31, 202078.88M23.50M42.43%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Medistim ASA 662.18M
Nordhealth AS 590.33M
Photocure ASA 537.59M
ArcticZymes Technologies ASA 109.99M
Omda AS 476.29M
Vistin Pharma ASA 455.25M
Nykode Therapeutics AS 73.37M
Lytix Biopharma AS 377.00K
Revenue Rankings